ADAMA Projects Narrower Losses in 2025 Amid Revenue Decline
Event summary
- ADAMA estimates a 1%–4% revenue decline in 2025 due to lower prices and portfolio optimization.
- Adjusted net profit expected at $4M–$54M, reversing a $206M loss in 2024.
- 'Fight Forward' transformation drove cost efficiencies but couldn't offset pricing pressures.
- Reported net loss narrowed to ($172M)–($122M), down from ($407M) in 2024.
The big picture
ADAMA's turnaround hinges on cost-cutting and strategic exits from commoditized products, but industry-wide pricing pressures threaten sustained profitability. The 'Fight Forward' plan's success will depend on balancing efficiency gains with revenue resilience in a high-interest-rate environment.
What we're watching
- Pricing Dynamics
- Whether ADAMA can stabilize prices amid overcapacity in active ingredients.
- Portfolio Strategy
- The pace at which portfolio optimization improves profitability.
- Regional Risks
- How Turkey's market volatility impacts ADAMA's recovery trajectory.
Our editorial coverage: